Treatment
226 - 240 of
366 Results
Sort Results:
Commentary:
FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions
January 2014
Article:
Sliding scale insulin is still giving patients a ride on the blood glucose roller coaster
January 2014
Article:
The Avandia (rosiglitazone) debate will heat up again now that FDA will loosen its restrictions
January 2014
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013
Article:
Nesina (nes-SEE-na, alogliptin) will compete for your prescription in a crowded market of gliptins for type 2 diabetes
August 2013